Company Filing History:
Years Active: 2021-2025
Title: Innovations in Cancer Treatment by Inventor Xiaoming Xu
Introduction
Xiaoming Xu is a notable inventor based in Fair Lawn, NJ (US), recognized for his contributions to cancer treatment through innovative compounds and methods. With a total of two patents, his work focuses on addressing critical challenges in treating hematological cancers.
Latest Patents
Xiaoming Xu's latest patents include significant advancements in the treatment of T-cell acute lymphoblastic leukemia. One patent discloses compounds, compositions, and methods for administering these compounds to patients in need. This innovation also encompasses compounds that inhibit two phosphoinositide 3-kinase (PI3K) isoforms, which are crucial in the treatment of non-Hodgkin lymphoma. Another patent introduces new compounds aimed at reducing c-Myc expression, particularly in aggressive B- and T-cell lymphomas. These compounds can be combined with adjunct c-Myc inhibitor agents to enhance the effectiveness of cancer therapies.
Career Highlights
Xiaoming Xu is affiliated with Columbia University, where he continues to advance research in cancer treatment. His work has garnered attention for its potential to improve patient outcomes in hematological cancers.
Collaborations
Xiaoming Xu collaborates with esteemed colleagues, including Donald W. Landry and Shi-Xian Deng, contributing to a rich environment of innovation and research.
Conclusion
Xiaoming Xu's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. His patents reflect a commitment to developing effective therapies for challenging diseases.